LMCG INVESTMENTS, LLC - SYNAGEVA BIOPHARMA CORP ownership

Quarter-by-quarter ownership
LMCG INVESTMENTS, LLC ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$5,496,000
+119.4%
56,342
+108.6%
0.12%
+109.1%
Q4 2014$2,505,00027,0050.06%
Other shareholders
SYNAGEVA BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 11,660,432$1,137,242,0009.46%
BB BIOTECH AG 1,025,476$100,015,0002.98%
EMORY UNIVERSITY 9,854$961,0001.82%
COLUMBIA WANGER ASSET MANAGEMENT LLC 3,245,542$316,538,0001.72%
New Leaf Venture Partners, L.L.C. 24,379$2,378,0001.61%
Alpha Wave Global, LP 304,000$29,649,0001.46%
Opus Point Partners Management, LLC 17,700$1,726,0001.45%
SECTORAL ASSET MANAGEMENT INC 365,684$35,665,0001.35%
Pier Capital, LLC 61,028$5,952,0000.90%
Tekla Capital Management LLC 198,689$19,378,0000.77%
View complete list of SYNAGEVA BIOPHARMA CORP shareholders